Hyperpolarized [1-13C]pyruvate MRS provides a unique imaging opportunity to study reaction kinetics and enzyme activities of in vivo metabolism both because of its favorable imaging characteristics as well as its critical position in the cellular metabolic pathway where it can either be reduced to lactate (reflecting glycolysis) or converted to acetyl-CoA and bicarbonate (reflecting oxidative phosphorylation).
Cancer tissue metabolism is altered in such a way as to result in a relative preponderance of glycolysis as compared to oxidative phosphorylation (i.e., Warburg effect). While there is a strong theoretical basis for presuming that readjusting the metabolic balance towards normal could alter tumor growth, a robust noninvasive in vivo tool with which to measure the balance between these two metabolic processes has yet to be developed.
Until recently, hyperpolarized 13C-pyruvate imaging studies have focused solely on [1-13C]lactate production because of its strong signal. However, without a concomitant measure of pyruvate entry into the mitochondria, the lactate signal provides no information on the balance between the glycolytic and oxidative metabolic pathways. Consistent measurement of 13C-bicarbonate in cancer tissue, which does provide such information, has proven difficult, however.
In this study, we report reliable measurement of 13C-bicarbonate production both in healthy brain and a highly glycolytic experimental glioblastoma model using an optimized 13C MRS imaging protocol. With the capacity to obtain signal in all tumors, we also confirm for the first time that the ratio of 13C-lactate-to-bicarbonate provides a more robust metric than does 13C-lactate for assessing the metabolic effects of an anti-angiogenic therapy. Our data suggest a potential application of this ratio as an early biomarker to assess therapeutic effectiveness. Furthermore, although further study is needed, the results suggest that anti-angiogenic treatment results in a rapid normalization in the relative tissue utilization of glycolytic and oxidative phosphorylation by tumor tissue.